GlassScriptPhysician profile
Kimberly S Moreland
NPI 1871572008
$1,690.15
in general payments reported to CMS, 2019-2025
20 companies · $293 in 2025
The $293 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2020: $153 · 2021: $848 · 2023: $50.75 · 2024: $177 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $521.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $822.25 | 2021-2024 | |
| Dexcom, INC. | $264.18 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Gynesonics, INC. | $117.90 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Therapeuticsmd, INC. | $84.41 | 2020 | |
| Hologic Sales and Service, LLC | $56.76 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $50.75 | 2023 | Myrisk |
| Meridian Bioscience INC. | $46.10 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.05 | 2019-2021 | |
| Allergan, INC. | $26.28 | 2020 | |
| Merck Sharp & Dohme LLC | $22.96 | 2019-2020 | |
| Roche Diagnostics Corporation | $20.58 | 2021 | |
| Daiichi Sankyo INC. | $19.67 | 2019 | |
| Lupin INC. | $17.03 | 2019 | |
| Teleflex LLC | $16.72 | 2019 | |
| Abbvie INC. | $16.24 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.21 | 2025 | |
| Biogen, INC. | $13.85 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $13.58 | 2021 | |
| Meditrina | $12.84 | 2024 | |
| Agile Therapeutics, INC. | $11.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Moreland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.